cellular process (GO:0009987) | 0.26 | 19 | TSC2, CREBBP, EDNRB, EDN3, AHNAK, GDNF, KDR, SEMA3D, IRAK3, PLAU, PTCH1, THBS4, NTF3, FBN1, DPYD, GFRA1, POLR2F, RET, ZHX2 |
biological regulation (GO:0065007) | 0.39 | 18 | TSC2, CREBBP, EDNRB, EDN3, AHNAK, GDNF, KDR, IRAK3, PLAU, PTCH1, NTF3, THBS4, FBN1, SEMA3D, GFRA1, POLR2F, RET, ZHX2 |
regulation of biological process (GO:0050789) | 0.45 | 18 | CREBBP, EDNRB, EDN3, TSC2, AHNAK, IRAK3, PLAU, PTCH1, NTF3, THBS4, FBN1, SEMA3D, KDR, GDNF, GFRA1, POLR2F, RET, ZHX2 |
single-organism process (GO:0044699) | 0.48 | 18 | CREBBP, EDNRB, EDN3, SEMA3D, TSC2, PLAU, PTCH1, THBS4, NTF3, FBN1, FAT3, DPYD, KDR, GDNF, GFRA1, POLR2F, RET, ZHX2 |
regulation of cellular process (GO:0050794) | 0.5 | 18 | TSC2, CREBBP, EDNRB, EDN3, AHNAK, GDNF, KDR, IRAK3, PLAU, PTCH1, NTF3, THBS4, FBN1, SEMA3D, GFRA1, POLR2F, RET, ZHX2 |
developmental process (GO:0032502) | 1.36 | 17 | TSC2, CREBBP, EDNRB, EDN3, GDNF, KDR, PLAU, PTCH1, NTF3, THBS4, FBN1, FAT3, SEMA3D, GFRA1, POLR2F, RET, ZHX2 |
single-organism developmental process (GO:0044767) | 1.49 | 16 | EDNRB, EDN3, GDNF, TSC2, RET, CREBBP, PTCH1, NTF3, THBS4, FBN1, ZHX2, SEMA3D, KDR, POLR2F, PLAU, FAT3 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 16 | EDNRB, EDN3, AHNAK, TSC2, RET, IRAK3, CREBBP, PTCH1, FBN1, NTF3, THBS4, GDNF, KDR, POLR2F, PLAU, ZHX2 |
regulation of metabolic process (GO:0019222) | 1.02 | 16 | TSC2, CREBBP, EDNRB, EDN3, KDR, AHNAK, IRAK3, PLAU, PTCH1, FBN1, NTF3, THBS4, GDNF, POLR2F, RET, ZHX2 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 15 | TSC2, EDNRB, EDN3, KDR, AHNAK, IRAK3, RET, PTCH1, FBN1, NTF3, THBS4, GDNF, POLR2F, CREBBP, ZHX2 |
single-organism cellular process (GO:0044763) | 0.65 | 15 | EDNRB, EDN3, GDNF, KDR, RET, PLAU, PTCH1, DPYD, NTF3, THBS4, FBN1, SEMA3D, GFRA1, POLR2F, CREBBP |
regulation of primary metabolic process (GO:0080090) | 1.08 | 15 | TSC2, EDNRB, EDN3, KDR, AHNAK, IRAK3, RET, PTCH1, FBN1, NTF3, THBS4, GDNF, POLR2F, CREBBP, ZHX2 |
negative regulation of biological process (GO:0048519) | 1.33 | 14 | EDNRB, GDNF, TSC2, IRAK3, PLAU, PTCH1, NTF3, THBS4, FBN1, SEMA3D, KDR, POLR2F, CREBBP, ZHX2 |
anatomical structure development (GO:0048856) | 1.58 | 14 | EDNRB, EDN3, GDNF, TSC2, PLAU, PTCH1, FBN1, NTF3, THBS4, SEMA3D, KDR, GFRA1, RET, FAT3 |
regulation of response to stimulus (GO:0048583) | 1.54 | 14 | CREBBP, EDNRB, EDN3, KDR, TSC2, IRAK3, PLAU, PTCH1, FBN1, NTF3, THBS4, SEMA3D, GDNF, RET |
signal transduction (GO:0007165) | 1.28 | 14 | CREBBP, EDNRB, TSC2, KDR, RET, IRAK3, PLAU, PTCH1, EDN3, NTF3, SEMA3D, GDNF, GFRA1, POLR2F |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 14 | CREBBP, EDNRB, EDN3, GDNF, KDR, IRAK3, PLAU, PTCH1, NTF3, THBS4, SEMA3D, POLR2F, RET, ZHX2 |
positive regulation of biological process (GO:0048518) | 1.2 | 13 | CREBBP, EDNRB, EDN3, GDNF, KDR, IRAK3, RET, PTCH1, THBS4, NTF3, SEMA3D, POLR2F, PLAU |
multicellular organismal process (GO:0032501) | 1.45 | 13 | EDNRB, CNTN5, GDNF, KDR, RET, PTCH1, EDN3, THBS4, FAT3, SEMA3D, POLR2F, PLAU, ZHX2 |
regulation of localization (GO:0032879) | 1.94 | 12 | TSC2, EDNRB, EDN3, GDNF, AHNAK, PLAU, PTCH1, THBS4, NTF3, SEMA3D, KDR, RET |
single-multicellular organism process (GO:0044707) | 1.78 | 12 | EDNRB, GDNF, KDR, PLAU, PTCH1, EDN3, THBS4, ZHX2, SEMA3D, POLR2F, RET, FAT3 |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 12 | EDNRB, KDR, TSC2, IRAK3, CREBBP, PTCH1, EDN3, NTF3, SEMA3D, GFRA1, POLR2F, RET |
positive regulation of cellular process (GO:0048522) | 1.3 | 12 | CREBBP, EDNRB, EDN3, GDNF, KDR, PLAU, PTCH1, NTF3, THBS4, SEMA3D, POLR2F, RET |
primary metabolic process (GO:0044238) | 0.69 | 11 | CREBBP, KDR, IRAK3, PLAU, PTCH1, DPYD, GDNF, GFRA1, POLR2F, RET, ZHX2 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 11 | CREBBP, EDNRB, EDN3, KDR, PLAU, PTCH1, THBS4, NTF3, GDNF, POLR2F, RET |
organic substance metabolic process (GO:0071704) | 0.63 | 11 | CREBBP, KDR, RET, IRAK3, PLAU, PTCH1, DPYD, GDNF, GFRA1, POLR2F, ZHX2 |
regulation of developmental process (GO:0050793) | 2.1 | 11 | EDNRB, GDNF, KDR, IRAK3, PLAU, PTCH1, NTF3, THBS4, SEMA3D, RET, ZHX2 |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 11 | CREBBP, EDNRB, EDN3, KDR, PLAU, PTCH1, THBS4, NTF3, GDNF, POLR2F, RET |
regulation of signal transduction (GO:0009966) | 1.84 | 11 | EDN3, KDR, TSC2, RET, IRAK3, CREBBP, PTCH1, FBN1, NTF3, GDNF, PLAU |
regulation of multicellular organismal development (GO:2000026) | 2.31 | 11 | EDNRB, GDNF, KDR, IRAK3, PLAU, PTCH1, NTF3, THBS4, SEMA3D, RET, ZHX2 |
metabolic process (GO:0008152) | 0.58 | 11 | CREBBP, KDR, IRAK3, PLAU, PTCH1, DPYD, GDNF, GFRA1, POLR2F, RET, ZHX2 |
regulation of signaling (GO:0023051) | 1.72 | 11 | CREBBP, EDN3, TSC2, KDR, IRAK3, PLAU, PTCH1, FBN1, NTF3, GDNF, RET |
regulation of molecular function (GO:0065009) | 1.78 | 11 | EDNRB, TSC2, AHNAK, IRAK3, PLAU, PTCH1, EDN3, NTF3, GDNF, GFRA1, RET |
regulation of cell communication (GO:0010646) | 1.73 | 11 | EDN3, KDR, TSC2, RET, IRAK3, CREBBP, PTCH1, FBN1, NTF3, GDNF, PLAU |
regulation of gene expression (GO:0010468) | 1.37 | 11 | EDNRB, AHNAK, IRAK3, RET, PTCH1, EDN3, FBN1, GDNF, POLR2F, CREBBP, ZHX2 |
negative regulation of cellular process (GO:0048523) | 1.41 | 11 | EDNRB, SEMA3D, TSC2, IRAK3, CREBBP, PTCH1, NTF3, FBN1, GDNF, KDR, ZHX2 |
locomotion (GO:0040011) | 2.91 | 10 | EDNRB, EDN3, SEMA3D, TSC2, PLAU, NTF3, THBS4, GDNF, KDR, RET |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 10 | EDNRB, EDN3, KDR, RET, PTCH1, THBS4, NTF3, GDNF, POLR2F, CREBBP |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 10 | EDNRB, AHNAK, IRAK3, RET, PTCH1, FBN1, GDNF, POLR2F, CREBBP, ZHX2 |
response to stimulus (GO:0050896) | 1.22 | 10 | EDNRB, KDR, RET, IRAK3, PLAU, PTCH1, THBS4, FBN1, POLR2F, CREBBP |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 10 | EDNRB, AHNAK, IRAK3, RET, PTCH1, FBN1, GDNF, POLR2F, CREBBP, ZHX2 |
regulation of biosynthetic process (GO:0009889) | 1.37 | 10 | EDNRB, KDR, IRAK3, RET, PTCH1, FBN1, GDNF, POLR2F, CREBBP, ZHX2 |
cellular metabolic process (GO:0044237) | 0.69 | 10 | KDR, RET, IRAK3, CREBBP, DPYD, GDNF, GFRA1, POLR2F, PLAU, ZHX2 |
macromolecule metabolic process (GO:0043170) | 0.83 | 10 | KDR, IRAK3, PLAU, PTCH1, RET, GDNF, GFRA1, POLR2F, CREBBP, ZHX2 |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 10 | EDNRB, KDR, IRAK3, RET, PTCH1, FBN1, GDNF, POLR2F, CREBBP, ZHX2 |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 10 | EDNRB, AHNAK, IRAK3, RET, PTCH1, FBN1, GDNF, POLR2F, CREBBP, ZHX2 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 10 | CREBBP, EDNRB, KDR, IRAK3, PLAU, EDN3, NTF3, GDNF, POLR2F, RET |
regulation of cell proliferation (GO:0042127) | 2.41 | 9 | EDNRB, KDR, TSC2, PLAU, PTCH1, NTF3, EDN3, THBS4, GDNF |
cellular response to stimulus (GO:0051716) | 1.97 | 9 | CREBBP, EDNRB, KDR, PLAU, PTCH1, FBN1, THBS4, POLR2F, RET |
cellular developmental process (GO:0048869) | 1.82 | 9 | EDNRB, SEMA3D, KDR, RET, PTCH1, NTF3, EDN3, THBS4, GDNF |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 9 | EDNRB, IRAK3, RET, PTCH1, FBN1, GDNF, POLR2F, CREBBP, ZHX2 |
cellular component organization (GO:0016043) | 1.24 | 9 | AHNAK, KDR, RET, PTCH1, FBN1, NTF3, THBS4, GDNF, CREBBP |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 9 | EDNRB, IRAK3, RET, PTCH1, FBN1, GDNF, POLR2F, CREBBP, ZHX2 |
regulation of cell differentiation (GO:0045595) | 2.42 | 9 | EDNRB, SEMA3D, KDR, RET, PTCH1, NTF3, EDN3, GDNF, ZHX2 |
response to chemical (GO:0042221) | 1.98 | 9 | EDNRB, KDR, RET, IRAK3, CREBBP, PTCH1, THBS4, FBN1, PLAU |
system development (GO:0048731) | 2.92 | 9 | EDNRB, GDNF, RET, PTCH1, FBN1, NTF3, THBS4, SEMA3D, GFRA1 |
regulation of biological quality (GO:0065008) | 1.68 | 9 | EDNRB, KDR, RET, CREBBP, PTCH1, FBN1, EDN3, GDNF, PLAU |
response to organic substance (GO:0010033) | 2.2 | 9 | CREBBP, EDNRB, KDR, IRAK3, PLAU, PTCH1, THBS4, FBN1, RET |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 9 | KDR, AHNAK, CREBBP, PTCH1, NTF3, FBN1, THBS4, GDNF, RET |
regulation of phosphorylation (GO:0042325) | 2.5 | 8 | EDNRB, EDN3, KDR, TSC2, IRAK3, RET, THBS4, NTF3 |
regulation of protein phosphorylation (GO:0001932) | 2.57 | 8 | EDNRB, EDN3, KDR, TSC2, IRAK3, RET, THBS4, NTF3 |
cell migration (GO:0016477) | 3.12 | 8 | EDNRB, GDNF, KDR, PLAU, EDN3, THBS4, SEMA3D, RET |
negative regulation of metabolic process (GO:0009892) | 1.93 | 8 | EDNRB, TSC2, IRAK3, CREBBP, PTCH1, NTF3, POLR2F, ZHX2 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 8 | EDNRB, TSC2, IRAK3, CREBBP, PTCH1, NTF3, POLR2F, ZHX2 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 8 | CREBBP, KDR, IRAK3, RET, GDNF, GFRA1, POLR2F, ZHX2 |
cell motility (GO:0048870) | 3.02 | 8 | EDNRB, SEMA3D, KDR, PLAU, EDN3, THBS4, GDNF, RET |
protein metabolic process (GO:0019538) | 1.45 | 8 | CREBBP, KDR, IRAK3, RET, PTCH1, GDNF, GFRA1, PLAU |
regulation of protein metabolic process (GO:0051246) | 1.93 | 8 | EDNRB, EDN3, KDR, TSC2, IRAK3, RET, THBS4, NTF3 |
regulation of catalytic activity (GO:0050790) | 1.97 | 8 | EDNRB, TSC2, IRAK3, RET, EDN3, NTF3, GDNF, GFRA1 |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 8 | EDNRB, IRAK3, RET, PTCH1, FBN1, GDNF, CREBBP, ZHX2 |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 8 | EDNRB, IRAK3, RET, PTCH1, FBN1, GDNF, CREBBP, ZHX2 |
regulation of cellular component organization (GO:0051128) | 2.01 | 8 | SEMA3D, TSC2, IRAK3, RET, NTF3, EDN3, GDNF, KDR |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 8 | EDNRB, EDN3, KDR, TSC2, IRAK3, RET, THBS4, NTF3 |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 8 | EDNRB, IRAK3, RET, PTCH1, FBN1, GDNF, CREBBP, ZHX2 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 8 | EDNRB, EDN3, KDR, TSC2, IRAK3, RET, THBS4, NTF3 |
regulation of protein modification process (GO:0031399) | 2.32 | 8 | EDNRB, KDR, TSC2, IRAK3, RET, EDN3, NTF3, THBS4 |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 8 | EDNRB, KDR, TSC2, IRAK3, RET, EDN3, NTF3, THBS4 |
movement of cell or subcellular component (GO:0006928) | 2.61 | 8 | EDNRB, GDNF, KDR, PLAU, THBS4, EDN3, SEMA3D, RET |
positive regulation of cell proliferation (GO:0008284) | 3.01 | 7 | EDNRB, KDR, PLAU, NTF3, EDN3, THBS4, GDNF |
positive regulation of cellular component movement (GO:0051272) | 3.71 | 7 | KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D, RET |
positive regulation of cell migration (GO:0030335) | 3.77 | 7 | KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D, RET |
regulation of locomotion (GO:0040012) | 3.12 | 7 | KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D, RET |
positive regulation of cell motility (GO:2000147) | 3.74 | 7 | KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D, RET |
positive regulation of locomotion (GO:0040017) | 3.71 | 7 | KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D, RET |
regulation of response to external stimulus (GO:0032101) | 3.06 | 7 | EDNRB, KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D |
regulation of transport (GO:0051049) | 2.24 | 7 | EDNRB, AHNAK, TSC2, PTCH1, EDN3, NTF3, GDNF |
negative regulation of response to stimulus (GO:0048585) | 2.52 | 7 | SEMA3D, TSC2, IRAK3, PLAU, PTCH1, FBN1, GDNF |
negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 7 | EDNRB, IRAK3, PLAU, PTCH1, THBS4, SEMA3D, ZHX2 |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 7 | EDNRB, TSC2, IRAK3, CREBBP, PTCH1, NTF3, ZHX2 |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 7 | KDR, TSC2, IRAK3, CREBBP, EDN3, NTF3, RET |
positive regulation of response to stimulus (GO:0048584) | 2.18 | 7 | KDR, IRAK3, RET, EDN3, NTF3, THBS4, CREBBP |
regulation of cellular component movement (GO:0051270) | 3.08 | 7 | KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D, RET |
regulation of cell motility (GO:2000145) | 3.16 | 7 | KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D, RET |
positive regulation of molecular function (GO:0044093) | 2.23 | 7 | TSC2, IRAK3, RET, EDN3, NTF3, GDNF, GFRA1 |
nervous system development (GO:0007399) | 3.53 | 7 | EDNRB, SEMA3D, RET, THBS4, NTF3, GDNF, GFRA1 |
intracellular signal transduction (GO:0035556) | 2.39 | 7 | EDNRB, KDR, TSC2, RET, EDN3, GDNF, GFRA1 |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 7 | RET, PTCH1, FBN1, NTF3, THBS4, GDNF, CREBBP |
regulation of cell migration (GO:0030334) | 3.23 | 7 | KDR, PLAU, NTF3, EDN3, THBS4, SEMA3D, RET |
positive regulation of biosynthetic process (GO:0009891) | 2.29 | 6 | KDR, CREBBP, PTCH1, GDNF, POLR2F, RET |
phosphorylation (GO:0016310) | 2.63 | 6 | KDR, IRAK3, PLAU, GDNF, GFRA1, RET |
cell differentiation (GO:0030154) | 2.14 | 6 | EDNRB, KDR, RET, PTCH1, EDN3, SEMA3D |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 6 | EDNRB, KDR, PLAU, PTCH1, FBN1, RET |
enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 6 | TSC2, KDR, RET, NTF3, POLR2F, GFRA1 |
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 3.54 | 6 | TSC2, KDR, RET, NTF3, POLR2F, GFRA1 |
ameboidal-type cell migration (GO:0001667) | 4.71 | 6 | EDNRB, SEMA3D, KDR, RET, EDN3, GDNF |
regulation of cell death (GO:0010941) | 2.43 | 6 | EDNRB, KDR, CREBBP, NTF3, GDNF, RET |
regulation of apoptotic process (GO:0042981) | 2.5 | 6 | EDNRB, KDR, CREBBP, NTF3, GDNF, RET |
positive regulation of catalytic activity (GO:0043085) | 2.4 | 6 | TSC2, RET, EDN3, NTF3, GDNF, GFRA1 |
cellular protein metabolic process (GO:0044267) | 1.63 | 6 | KDR, IRAK3, CREBBP, GDNF, GFRA1, RET |
single-organism metabolic process (GO:0044710) | 1.63 | 6 | KDR, RET, DPYD, GDNF, GFRA1, CREBBP |
taxis (GO:0042330) | 4.03 | 6 | EDNRB, TSC2, PLAU, EDN3, NTF3, SEMA3D |
positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 6 | EDNRB, KDR, RET, EDN3, NTF3, THBS4 |
regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 6 | SEMA3D, KDR, PLAU, THBS4, GDNF, RET |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 6 | EDNRB, KDR, RET, EDN3, NTF3, THBS4 |
regulation of cell development (GO:0060284) | 3.01 | 6 | EDNRB, SEMA3D, RET, NTF3, GDNF, ZHX2 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 6 | KDR, IRAK3, RET, GDNF, GFRA1, PLAU |
regulation of programmed cell death (GO:0043067) | 2.49 | 6 | EDNRB, KDR, CREBBP, NTF3, GDNF, RET |
animal organ development (GO:0048513) | 2.53 | 6 | KDR, TSC2, RET, PTCH1, FBN1, GDNF |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 6 | EDNRB, KDR, RET, EDN3, NTF3, THBS4 |
anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 6 | KDR, TSC2, RET, PTCH1, GDNF, PLAU |
chemotaxis (GO:0006935) | 4.04 | 6 | EDNRB, TSC2, PLAU, EDN3, NTF3, SEMA3D |
positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 6 | EDNRB, KDR, RET, EDN3, NTF3, THBS4 |
cellular protein modification process (GO:0006464) | 1.79 | 6 | KDR, IRAK3, CREBBP, GDNF, GFRA1, RET |
cellular response to organic substance (GO:0071310) | 2.78 | 6 | EDNRB, KDR, RET, PTCH1, FBN1, PLAU |
positive regulation of cell differentiation (GO:0045597) | 3.01 | 6 | KDR, RET, PTCH1, EDN3, NTF3, GDNF |
macromolecule modification (GO:0043412) | 1.73 | 6 | KDR, IRAK3, CREBBP, GDNF, GFRA1, RET |
protein modification process (GO:0036211) | 1.79 | 6 | KDR, IRAK3, CREBBP, GDNF, GFRA1, RET |
response to oxygen-containing compound (GO:1901700) | 2.57 | 6 | EDNRB, IRAK3, RET, PTCH1, FBN1, PLAU |
positive regulation of phosphorylation (GO:0042327) | 2.9 | 6 | EDNRB, KDR, RET, EDN3, NTF3, THBS4 |
positive regulation of developmental process (GO:0051094) | 2.77 | 6 | KDR, IRAK3, RET, PTCH1, NTF3, GDNF |
positive regulation of protein modification process (GO:0031401) | 2.7 | 6 | EDNRB, KDR, RET, EDN3, NTF3, THBS4 |
response to stress (GO:0006950) | 1.8 | 6 | EDNRB, RET, CREBBP, THBS4, POLR2F, PLAU |
positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 6 | KDR, CREBBP, PTCH1, GDNF, POLR2F, RET |
regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 6 | EDNRB, CREBBP, PTCH1, FBN1, GDNF, ZHX2 |
phosphorus metabolic process (GO:0006793) | 2.15 | 6 | KDR, IRAK3, PLAU, GDNF, GFRA1, RET |
positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 6 | EDNRB, KDR, RET, EDN3, NTF3, THBS4 |
positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 5 | CREBBP, RET, PTCH1, POLR2F, GDNF |
immune system process (GO:0002376) | 2.29 | 5 | IRAK3, CREBBP, EDNRB, EDN3, RET |
homeostatic process (GO:0042592) | 2.61 | 5 | CREBBP, PLAU, EDN3, PTCH1, EDNRB |
negative regulation of signaling (GO:0023057) | 2.65 | 5 | IRAK3, FBN1, PTCH1, GDNF, TSC2 |
negative regulation of gene expression (GO:0010629) | 2.48 | 5 | CREBBP, EDNRB, PTCH1, POLR2F, ZHX2 |
positive regulation of gene expression (GO:0010628) | 2.35 | 5 | CREBBP, POLR2F, PTCH1, RET, GDNF |
regulation of chemotaxis (GO:0050920) | 4.53 | 5 | THBS4, EDN3, NTF3, SEMA3D, KDR |
negative regulation of cell communication (GO:0010648) | 2.66 | 5 | IRAK3, FBN1, PTCH1, GDNF, TSC2 |
positive regulation of cell communication (GO:0010647) | 2.41 | 5 | CREBBP, EDN3, NTF3, KDR, RET |
regulation of GTPase activity (GO:0043087) | 3.21 | 5 | GFRA1, GDNF, NTF3, TSC2, RET |
multicellular organism development (GO:0007275) | 2.54 | 5 | EDN3, PTCH1, SEMA3D, FAT3, KDR |
regulation of neurogenesis (GO:0050767) | 3.21 | 5 | EDNRB, RET, NTF3, ZHX2, SEMA3D |
positive regulation of GTPase activity (GO:0043547) | 3.28 | 5 | NTF3, GDNF, GFRA1, TSC2, RET |
negative regulation of signal transduction (GO:0009968) | 2.75 | 5 | IRAK3, FBN1, PTCH1, GDNF, TSC2 |
positive regulation of signal transduction (GO:0009967) | 2.5 | 5 | CREBBP, EDN3, NTF3, KDR, RET |
regulation of neuron differentiation (GO:0045664) | 3.39 | 5 | EDNRB, RET, NTF3, ZHX2, SEMA3D |
biological adhesion (GO:0022610) | 2.81 | 5 | CREBBP, THBS4, CNTN5, RET, FAT3 |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 5 | EDN3, GDNF, NTF3, KDR, RET |
negative regulation of developmental process (GO:0051093) | 3.17 | 5 | THBS4, EDNRB, PTCH1, SEMA3D, ZHX2 |
protein phosphorylation (GO:0006468) | 2.89 | 5 | IRAK3, GFRA1, GDNF, RET, KDR |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 5 | POLR2F, CREBBP, PTCH1, RET, GDNF |
positive regulation of transport (GO:0051050) | 2.9 | 5 | NTF3, EDN3, PTCH1, EDNRB, GDNF |
tissue development (GO:0009888) | 3.27 | 5 | RET, GDNF, PTCH1, PLAU, KDR |
cell adhesion (GO:0007155) | 2.82 | 5 | THBS4, CNTN5, CREBBP, FAT3, RET |
positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 5 | POLR2F, RET, PTCH1, CREBBP, GDNF |
neural crest cell migration (GO:0001755) | 5.76 | 5 | EDNRB, GDNF, EDN3, SEMA3D, RET |
localization (GO:0051179) | 1.4 | 5 | EDNRB, FBN1, PTCH1, EDN3, TSC2 |
positive regulation of signaling (GO:0023056) | 2.41 | 5 | CREBBP, EDN3, NTF3, KDR, RET |
regulation of hydrolase activity (GO:0051336) | 2.53 | 5 | NTF3, GDNF, GFRA1, TSC2, RET |
cellular response to oxygen-containing compound (GO:1901701) | 3.22 | 5 | EDNRB, FBN1, PTCH1, RET, PLAU |
regulation of epithelial cell proliferation (GO:0050678) | 4.06 | 5 | THBS4, EDNRB, PTCH1, PLAU, KDR |
positive regulation of hydrolase activity (GO:0051345) | 2.91 | 5 | NTF3, GDNF, GFRA1, TSC2, RET |
positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 5 | POLR2F, RET, PTCH1, CREBBP, GDNF |
positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 5 | CREBBP, POLR2F, PTCH1, RET, GDNF |
regulation of nervous system development (GO:0051960) | 3.1 | 5 | EDNRB, RET, NTF3, ZHX2, SEMA3D |
response to lipid (GO:0033993) | 3.11 | 5 | IRAK3, EDNRB, PTCH1, RET, PLAU |
regulation of cell morphogenesis (GO:0022604) | 3.4 | 4 | RET, GDNF, KDR, SEMA3D |
negative regulation of phosphorus metabolic process (GO:0010563) | 3.45 | 4 | IRAK3, EDNRB, NTF3, TSC2 |
positive regulation of response to external stimulus (GO:0032103) | 4.17 | 4 | THBS4, EDN3, NTF3, KDR |
negative regulation of biosynthetic process (GO:0009890) | 2.47 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
tube formation (GO:0035148) | 4.98 | 4 | RET, PTCH1, GDNF, TSC2 |
cellular biosynthetic process (GO:0044249) | 1.37 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
positive regulation of chemotaxis (GO:0050921) | 4.94 | 4 | THBS4, EDN3, NTF3, KDR |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
organic substance biosynthetic process (GO:1901576) | 1.34 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
response to organic cyclic compound (GO:0014070) | 3.07 | 4 | IRAK3, EDNRB, PTCH1, PLAU |
regulation of MAPK cascade (GO:0043408) | 3.22 | 4 | IRAK3, EDN3, NTF3, KDR |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
negative regulation of protein metabolic process (GO:0051248) | 2.82 | 4 | IRAK3, EDNRB, NTF3, TSC2 |
negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
heterocycle metabolic process (GO:0046483) | 1.31 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
regulation of kinase activity (GO:0043549) | 3.07 | 4 | IRAK3, EDN3, NTF3, TSC2 |
negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
interspecies interaction between organisms (GO:0044419) | 3.08 | 4 | IRAK3, CREBBP, KDR, TSC2 |
positive regulation of immune system process (GO:0002684) | 2.96 | 4 | IRAK3, CREBBP, THBS4, EDN3 |
negative regulation of apoptotic process (GO:0043066) | 3.04 | 4 | EDNRB, NTF3, GDNF, KDR |
regulation of immune system process (GO:0002682) | 2.5 | 4 | IRAK3, CREBBP, EDN3, THBS4 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
transport (GO:0006810) | 1.51 | 4 | EDNRB, PTCH1, EDN3, TSC2 |
negative regulation of molecular function (GO:0044092) | 2.74 | 4 | IRAK3, EDNRB, PTCH1, TSC2 |
signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 4 | GFRA1, GDNF, KDR, RET |
system process (GO:0003008) | 2.3 | 4 | EDN3, CNTN5, EDNRB, GDNF |
negative regulation of programmed cell death (GO:0043069) | 3.02 | 4 | EDNRB, NTF3, GDNF, KDR |
positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 4 | RET, PTCH1, CREBBP, GDNF |
epithelium development (GO:0060429) | 4.57 | 4 | RET, PTCH1, KDR, GDNF |
negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
viral process (GO:0016032) | 3.15 | 4 | IRAK3, CREBBP, KDR, TSC2 |
negative regulation of phosphate metabolic process (GO:0045936) | 3.45 | 4 | IRAK3, EDNRB, NTF3, TSC2 |
cell-cell adhesion (GO:0098609) | 3.34 | 4 | THBS4, CREBBP, FAT3, RET |
negative regulation of cell death (GO:0060548) | 2.95 | 4 | EDNRB, NTF3, GDNF, KDR |
regulation of protein kinase activity (GO:0045859) | 3.15 | 4 | IRAK3, EDN3, NTF3, TSC2 |
cellular response to lipid (GO:0071396) | 3.96 | 4 | EDNRB, PTCH1, PLAU, RET |
negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
negative regulation of cell differentiation (GO:0045596) | 3.33 | 4 | EDNRB, PTCH1, SEMA3D, ZHX2 |
single-organism transport (GO:0044765) | 2.18 | 4 | EDNRB, PTCH1, EDN3, TSC2 |
multi-organism cellular process (GO:0044764) | 3.14 | 4 | IRAK3, CREBBP, KDR, TSC2 |
negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 4 | CREBBP, PTCH1, RET, GDNF |
negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 4 | CREBBP, EDN3, NTF3, KDR |
establishment of localization (GO:0051234) | 1.48 | 4 | EDNRB, PTCH1, EDN3, TSC2 |
negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
single-organism localization (GO:1902578) | 2.09 | 4 | EDNRB, PTCH1, EDN3, TSC2 |
multi-organism process (GO:0051704) | 2.65 | 4 | IRAK3, CREBBP, KDR, TSC2 |
negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 4 | IRAK3, EDNRB, NTF3, TSC2 |
response to external stimulus (GO:0009605) | 2.55 | 4 | IRAK3, EDNRB, PTCH1, PLAU |
regulation of cell cycle (GO:0051726) | 2.93 | 4 | EDN3, PTCH1, CREBBP, TSC2 |
regulation of response to stress (GO:0080134) | 2.53 | 4 | IRAK3, EDNRB, CREBBP, PLAU |
biosynthetic process (GO:0009058) | 1.32 | 4 | POLR2F, DPYD, CREBBP, ZHX2 |
regulation of transferase activity (GO:0051338) | 2.88 | 4 | IRAK3, EDN3, NTF3, TSC2 |
chemical homeostasis (GO:0048878) | 2.97 | 4 | EDNRB, PTCH1, EDN3, PLAU |
cellular response to stress (GO:0033554) | 2.51 | 4 | CREBBP, THBS4, POLR2F, PLAU |
symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 4 | IRAK3, CREBBP, KDR, TSC2 |
negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 4 | EDNRB, PTCH1, CREBBP, ZHX2 |
cellular homeostasis (GO:0019725) | 3.23 | 3 | EDNRB, EDN3, PLAU |
response to nitrogen compound (GO:1901698) | 3.12 | 3 | IRAK3, PLAU, FBN1 |
cellular component assembly (GO:0022607) | 2.14 | 3 | THBS4, CREBBP, AHNAK |
RNA biosynthetic process (GO:0032774) | 1.84 | 3 | POLR2F, CREBBP, ZHX2 |
regulation of secretion (GO:0051046) | 3.2 | 3 | EDNRB, EDN3, GDNF |
positive regulation of secretion (GO:0051047) | 3.85 | 3 | EDNRB, EDN3, GDNF |
cell projection organization (GO:0030030) | 3.14 | 3 | THBS4, NTF3, GDNF |
regulation of cell adhesion (GO:0030155) | 3.27 | 3 | RET, PLAU, KDR |
cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 3 | POLR2F, CREBBP, ZHX2 |
kidney development (GO:0001822) | 4.79 | 3 | RET, FBN1, GDNF |
nucleic acid metabolic process (GO:0090304) | 1.46 | 3 | POLR2F, CREBBP, ZHX2 |
leukocyte migration (GO:0050900) | 4.19 | 3 | EDN3, EDNRB, RET |
peptidyl-amino acid modification (GO:0018193) | 2.98 | 3 | RET, CREBBP, KDR |
second-messenger-mediated signaling (GO:0019932) | 4.65 | 3 | EDN3, EDNRB, KDR |
negative regulation of cell development (GO:0010721) | 4.02 | 3 | EDNRB, SEMA3D, ZHX2 |
response to lipopolysaccharide (GO:0032496) | 4.03 | 3 | IRAK3, EDNRB, PLAU |
regulation of protein serine/threonine kinase activity (GO:0071900) | 3.58 | 3 | IRAK3, EDN3, NTF3 |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 3 | POLR2F, CREBBP, ZHX2 |
negative regulation of catalytic activity (GO:0043086) | 3.0 | 3 | IRAK3, EDNRB, TSC2 |
regulation of defense response (GO:0031347) | 3.11 | 3 | IRAK3, EDNRB, CREBBP |
response to endogenous stimulus (GO:0009719) | 2.79 | 3 | IRAK3, PLAU, FBN1 |
macromolecular complex assembly (GO:0065003) | 2.55 | 3 | THBS4, CREBBP, AHNAK |
regulation of mitotic cell cycle (GO:0007346) | 3.71 | 3 | EDN3, PTCH1, CREBBP |
neuron differentiation (GO:0030182) | 4.17 | 3 | EDN3, PTCH1, RET |
response to external biotic stimulus (GO:0043207) | 3.13 | 3 | IRAK3, EDNRB, PLAU |
cellular response to growth factor stimulus (GO:0071363) | 4.27 | 3 | PLAU, FBN1, KDR |
regulation of organelle organization (GO:0033043) | 2.72 | 3 | EDN3, NTF3, KDR |
MAPK cascade (GO:0000165) | 3.91 | 3 | GFRA1, RET, GDNF |
response to growth factor (GO:0070848) | 4.14 | 3 | PLAU, FBN1, KDR |
negative regulation of neurogenesis (GO:0050768) | 4.22 | 3 | EDNRB, SEMA3D, ZHX2 |
regulation of anatomical structure size (GO:0090066) | 3.78 | 3 | EDNRB, EDN3, RET |
negative regulation of neuron differentiation (GO:0045665) | 4.45 | 3 | EDNRB, SEMA3D, ZHX2 |
macromolecular complex subunit organization (GO:0043933) | 2.14 | 3 | THBS4, CREBBP, AHNAK |
regulation of cell morphogenesis involved in differentiation (GO:0010769) | 3.91 | 3 | RET, SEMA3D, GDNF |
nucleic acid-templated transcription (GO:0097659) | 1.91 | 3 | POLR2F, CREBBP, ZHX2 |
positive regulation of cell development (GO:0010720) | 3.57 | 3 | NTF3, RET, GDNF |
organic substance transport (GO:0071702) | 2.15 | 3 | EDN3, PTCH1, TSC2 |
proteolysis (GO:0006508) | 2.73 | 3 | PLAU, PTCH1, RET |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 3 | POLR2F, CREBBP, ZHX2 |
embryonic morphogenesis (GO:0048598) | 3.72 | 3 | CREBBP, PTCH1, FBN1 |
embryonic epithelial tube formation (GO:0001838) | 6.4 | 3 | RET, PTCH1, GDNF |
tissue morphogenesis (GO:0048729) | 3.87 | 3 | RET, PTCH1, GDNF |
muscle contraction (GO:0006936) | 4.37 | 3 | EDNRB, EDN3, GDNF |
response to abiotic stimulus (GO:0009628) | 2.8 | 3 | CREBBP, PTCH1, PLAU |
phasic smooth muscle contraction (GO:0014821) | 6.96 | 3 | EDNRB, EDN3, GDNF |
smooth muscle contraction (GO:0006939) | 5.9 | 3 | EDN3, EDNRB, GDNF |
protein complex assembly (GO:0006461) | 2.78 | 3 | THBS4, CREBBP, AHNAK |
positive regulation of MAPK cascade (GO:0043410) | 3.57 | 3 | EDN3, NTF3, KDR |
regulation of multi-organism process (GO:0043900) | 3.6 | 3 | EDNRB, POLR2F, PLAU |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 3 | POLR2F, CREBBP, ZHX2 |
metanephros development (GO:0001656) | 6.02 | 3 | RET, FBN1, GDNF |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 3 | POLR2F, CREBBP, ZHX2 |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 3 | POLR2F, CREBBP, ZHX2 |
cellular chemical homeostasis (GO:0055082) | 3.4 | 3 | EDNRB, EDN3, PLAU |
cellular component morphogenesis (GO:0032989) | 3.5 | 3 | THBS4, NTF3, GDNF |
negative regulation of protein phosphorylation (GO:0001933) | 3.79 | 3 | IRAK3, NTF3, TSC2 |
epithelial tube formation (GO:0072175) | 6.36 | 3 | RET, PTCH1, GDNF |
RNA metabolic process (GO:0016070) | 1.59 | 3 | POLR2F, CREBBP, ZHX2 |
positive regulation of multi-organism process (GO:0043902) | 4.68 | 3 | EDNRB, POLR2F, PLAU |
negative regulation of phosphorylation (GO:0042326) | 3.7 | 3 | IRAK3, NTF3, TSC2 |
response to biotic stimulus (GO:0009607) | 3.09 | 3 | IRAK3, EDNRB, PLAU |
protein complex subunit organization (GO:0071822) | 2.6 | 3 | THBS4, CREBBP, AHNAK |
response to organonitrogen compound (GO:0010243) | 3.2 | 3 | IRAK3, PLAU, FBN1 |
positive regulation of organelle organization (GO:0010638) | 3.38 | 3 | EDN3, NTF3, KDR |
muscle system process (GO:0003012) | 4.18 | 3 | EDN3, EDNRB, GDNF |
regulation of cytokine production (GO:0001817) | 3.4 | 3 | IRAK3, POLR2F, CREBBP |
negative regulation of nervous system development (GO:0051961) | 4.15 | 3 | EDNRB, SEMA3D, ZHX2 |
response to molecule of bacterial origin (GO:0002237) | 3.99 | 3 | IRAK3, EDNRB, PLAU |
transcription, DNA-templated (GO:0006351) | 1.91 | 3 | POLR2F, CREBBP, ZHX2 |
enteric nervous system development (GO:0048484) | 7.33 | 3 | EDNRB, RET, GDNF |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 3 | POLR2F, CREBBP, ZHX2 |
regulation of MAP kinase activity (GO:0043405) | 3.95 | 3 | IRAK3, EDN3, NTF3 |
negative regulation of protein modification process (GO:0031400) | 3.4 | 3 | IRAK3, NTF3, TSC2 |
regulation of extrinsic apoptotic signaling pathway (GO:2001236) | 4.69 | 2 | RET, GDNF |
protein localization (GO:0008104) | 2.36 | 2 | PTCH1, TSC2 |
regulation of apoptotic signaling pathway (GO:2001233) | 3.83 | 2 | RET, GDNF |
positive regulation of reproductive process (GO:2000243) | 5.8 | 2 | EDNRB, PLAU |
regulation of reproductive process (GO:2000241) | 4.88 | 2 | EDNRB, PLAU |
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239) | 5.86 | 2 | RET, GDNF |
behavior (GO:0007610) | 3.47 | 2 | THBS4, GDNF |
regulation of homeostatic process (GO:0032844) | 3.65 | 2 | EDNRB, KDR |
positive regulation of defense response (GO:0031349) | 3.83 | 2 | IRAK3, CREBBP |
membrane organization (GO:0061024) | 3.04 | 2 | PTCH1, GDNF |
regulation of positive chemotaxis (GO:0050926) | 6.55 | 2 | NTF3, KDR |
circulatory system process (GO:0003013) | 4.38 | 2 | EDN3, EDNRB |
negative regulation of neuron apoptotic process (GO:0043524) | 4.82 | 2 | NTF3, GDNF |
calcium ion homeostasis (GO:0055074) | 3.97 | 2 | EDN3, EDNRB |
cell chemotaxis (GO:0060326) | 4.63 | 2 | EDN3, EDNRB |
inorganic ion homeostasis (GO:0098771) | 3.43 | 2 | EDN3, EDNRB |
regulation of ion transmembrane transport (GO:0034765) | 3.77 | 2 | EDN3, AHNAK |
regulation of cell projection organization (GO:0031344) | 3.38 | 2 | RET, SEMA3D |
regulation of transmembrane transport (GO:0034762) | 3.74 | 2 | EDN3, AHNAK |
response to pain (GO:0048265) | 6.78 | 2 | EDNRB, RET |
positive regulation of cell cycle (GO:0045787) | 3.94 | 2 | EDN3, CREBBP |
positive regulation of cell adhesion (GO:0045785) | 3.79 | 2 | RET, KDR |
single-organism behavior (GO:0044708) | 3.79 | 2 | THBS4, GDNF |
peptidyl-tyrosine modification (GO:0018212) | 4.47 | 2 | RET, KDR |
positive regulation of metanephros development (GO:0072216) | 7.09 | 2 | RET, GDNF |
regulation of epithelial cell differentiation (GO:0030856) | 4.96 | 2 | PTCH1, GDNF |
response to acid chemical (GO:0001101) | 4.05 | 2 | RET, PTCH1 |
positive regulation of epithelial cell differentiation (GO:0030858) | 5.76 | 2 | PTCH1, GDNF |
macromolecule localization (GO:0033036) | 2.34 | 2 | PTCH1, TSC2 |
positive regulation of positive chemotaxis (GO:0050927) | 6.59 | 2 | NTF3, KDR |
vascular smooth muscle contraction (GO:0014829) | 7.16 | 2 | EDNRB, EDN3 |
leukocyte chemotaxis (GO:0030595) | 4.96 | 2 | EDNRB, EDN3 |
cellular response to molecule of bacterial origin (GO:0071219) | 4.88 | 2 | EDNRB, PLAU |
single organism signaling (GO:0044700) | 3.25 | 2 | EDN3, NTF3 |
carbohydrate homeostasis (GO:0033500) | 4.6 | 2 | PLAU, PTCH1 |
pigment cell differentiation (GO:0050931) | 6.64 | 2 | EDNRB, EDN3 |
sensory perception (GO:0007600) | 2.93 | 2 | EDNRB, CNTN5 |
vein smooth muscle contraction (GO:0014826) | 8.34 | 2 | EDN3, EDNRB |
establishment of protein localization (GO:0045184) | 2.53 | 2 | PTCH1, TSC2 |
regulation of immune response (GO:0050776) | 2.98 | 2 | IRAK3, CREBBP |
regulation of neuron projection development (GO:0010975) | 3.69 | 2 | RET, SEMA3D |
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433) | 4.82 | 2 | IRAK3, PTCH1 |
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742) | 4.39 | 2 | RET, FAT3 |
positive regulation of epithelial cell proliferation (GO:0050679) | 4.67 | 2 | THBS4, KDR |
cellular calcium ion homeostasis (GO:0006874) | 4.01 | 2 | EDNRB, EDN3 |
stem cell population maintenance (GO:0019827) | 4.83 | 2 | POLR2F, ZHX2 |
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731) | 4.62 | 2 | THBS4, NTF3 |
regulation of peptidyl-tyrosine phosphorylation (GO:0050730) | 4.35 | 2 | THBS4, NTF3 |
cellular response to lipopolysaccharide (GO:0071222) | 4.94 | 2 | EDNRB, PLAU |
cellular macromolecule localization (GO:0070727) | 3.1 | 2 | PTCH1, TSC2 |
cell communication (GO:0007154) | 3.04 | 2 | EDN3, NTF3 |
regulation of neuron apoptotic process (GO:0043523) | 4.47 | 2 | NTF3, GDNF |
multicellular organismal response to stress (GO:0033555) | 5.67 | 2 | EDNRB, RET |
aromatic compound catabolic process (GO:0019439) | 3.79 | 2 | DPYD, ZHX2 |
negative regulation of kinase activity (GO:0033673) | 4.22 | 2 | IRAK3, TSC2 |
positive regulation of kinase activity (GO:0033674) | 3.54 | 2 | EDN3, NTF3 |
embryonic organ development (GO:0048568) | 4.86 | 2 | PTCH1, KDR |
positive regulation of kidney development (GO:0090184) | 6.02 | 2 | RET, GDNF |
regulation of kidney development (GO:0090183) | 5.72 | 2 | RET, GDNF |
muscle cell migration (GO:0014812) | 6.84 | 2 | THBS4, PLAU |
positive regulation of immune response (GO:0050778) | 3.4 | 2 | IRAK3, CREBBP |
vascular process in circulatory system (GO:0003018) | 4.65 | 2 | EDNRB, EDN3 |
regulation of vasculature development (GO:1901342) | 4.26 | 2 | THBS4, KDR |
morphogenesis of a branching structure (GO:0001763) | 4.71 | 2 | PTCH1, GDNF |
vasoconstriction (GO:0042310) | 6.36 | 2 | EDNRB, EDN3 |
positive regulation of protein serine/threonine kinase activity (GO:0071902) | 4.06 | 2 | EDN3, NTF3 |
regulation of cation transmembrane transport (GO:1904062) | 4.4 | 2 | EDN3, AHNAK |
positive regulation of cell cycle process (GO:0090068) | 4.25 | 2 | EDN3, CREBBP |
organic substance catabolic process (GO:1901575) | 2.45 | 2 | DPYD, ZHX2 |
positive regulation of transferase activity (GO:0051347) | 3.31 | 2 | EDN3, NTF3 |
immune response-regulating signaling pathway (GO:0002764) | 3.72 | 2 | IRAK3, CREBBP |
intracellular protein transport (GO:0006886) | 3.2 | 2 | PTCH1, TSC2 |
negative regulation of transferase activity (GO:0051348) | 3.87 | 2 | IRAK3, TSC2 |
positive regulation of leukocyte migration (GO:0002687) | 5.05 | 2 | THBS4, EDN3 |
regulation of leukocyte migration (GO:0002685) | 4.72 | 2 | THBS4, EDN3 |
transcription initiation from RNA polymerase II promoter (GO:0006367) | 4.7 | 2 | POLR2F, CREBBP |
negative regulation of developmental growth (GO:0048640) | 5.25 | 2 | PTCH1, SEMA3D |
cellular response to biotic stimulus (GO:0071216) | 4.76 | 2 | EDNRB, PLAU |
neural tube closure (GO:0001843) | 5.38 | 2 | PTCH1, TSC2 |
organic cyclic compound catabolic process (GO:1901361) | 3.73 | 2 | DPYD, ZHX2 |
negative regulation of intracellular signal transduction (GO:1902532) | 3.63 | 2 | IRAK3, TSC2 |
regulation of leukocyte chemotaxis (GO:0002688) | 5.17 | 2 | THBS4, EDN3 |
regulation of tube size (GO:0035150) | 4.79 | 2 | EDNRB, EDN3 |
organ morphogenesis (GO:0009887) | 3.55 | 2 | FBN1, PTCH1 |
single organism cell adhesion (GO:0098602) | 3.63 | 2 | THBS4, RET |
response to cytokine (GO:0034097) | 3.84 | 2 | IRAK3, CREBBP |
heterocycle catabolic process (GO:0046700) | 3.82 | 2 | DPYD, ZHX2 |
tube closure (GO:0060606) | 5.36 | 2 | PTCH1, TSC2 |
maintenance of cell number (GO:0098727) | 4.82 | 2 | POLR2F, ZHX2 |
positive regulation of type I interferon production (GO:0032481) | 5.48 | 2 | POLR2F, CREBBP |
single-organism membrane organization (GO:0044802) | 3.19 | 2 | PTCH1, GDNF |
somatic stem cell population maintenance (GO:0035019) | 5.52 | 2 | POLR2F, ZHX2 |
nucleobase-containing compound catabolic process (GO:0034655) | 3.9 | 2 | DPYD, ZHX2 |
regulation of neuron death (GO:1901214) | 4.19 | 2 | NTF3, GDNF |
negative regulation of neuron death (GO:1901215) | 4.57 | 2 | NTF3, GDNF |
extracellular matrix organization (GO:0030198) | 4.01 | 2 | FBN1, KDR |
mRNA metabolic process (GO:0016071) | 3.33 | 2 | POLR2F, ZHX2 |
immune response-activating signal transduction (GO:0002757) | 3.8 | 2 | IRAK3, CREBBP |
cellular nitrogen compound catabolic process (GO:0044270) | 3.8 | 2 | DPYD, ZHX2 |
intracellular transport (GO:0046907) | 2.67 | 2 | PTCH1, TSC2 |
peripheral nervous system development (GO:0007422) | 6.47 | 2 | EDNRB, GDNF |
response to decreased oxygen levels (GO:0036293) | 4.09 | 2 | CREBBP, PLAU |
cellular response to nitrogen compound (GO:1901699) | 3.79 | 2 | PLAU, FBN1 |
innate immune response-activating signal transduction (GO:0002758) | 4.45 | 2 | IRAK3, CREBBP |
regulation of growth (GO:0040008) | 3.26 | 2 | PTCH1, SEMA3D |
activation of innate immune response (GO:0002218) | 4.41 | 2 | IRAK3, CREBBP |
regulation of smoothened signaling pathway (GO:0008589) | 5.62 | 2 | CREBBP, PTCH1 |
neuron projection morphogenesis (GO:0048812) | 4.34 | 2 | THBS4, NTF3 |
positive regulation of leukocyte chemotaxis (GO:0002690) | 5.35 | 2 | THBS4, EDN3 |
DNA-templated transcription, initiation (GO:0006352) | 4.49 | 2 | POLR2F, CREBBP |
regulation of developmental growth (GO:0048638) | 4.04 | 2 | PTCH1, SEMA3D |
negative regulation of response to external stimulus (GO:0032102) | 4.18 | 2 | PLAU, SEMA3D |
posterior midgut development (GO:0007497) | 9.04 | 2 | EDNRB, RET |
ion homeostasis (GO:0050801) | 3.42 | 2 | EDN3, EDNRB |
establishment of localization in cell (GO:0051649) | 2.47 | 2 | PTCH1, TSC2 |
negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | IRAK3, SEMA3D |
modulation of synaptic transmission (GO:0050804) | 4.09 | 2 | NTF3, GDNF |
cellular catabolic process (GO:0044248) | 2.62 | 2 | DPYD, ZHX2 |
positive regulation of MAP kinase activity (GO:0043406) | 4.39 | 2 | EDN3, NTF3 |
signaling (GO:0023052) | 3.25 | 2 | EDN3, NTF3 |
regulation of secretion by cell (GO:1903530) | 3.28 | 2 | EDN3, GDNF |
positive regulation of secretion by cell (GO:1903532) | 3.93 | 2 | EDN3, GDNF |
positive regulation of peptidyl-serine phosphorylation (GO:0033138) | 5.26 | 2 | NTF3, RET |
response to hypoxia (GO:0001666) | 4.13 | 2 | CREBBP, PLAU |
protein autophosphorylation (GO:0046777) | 4.46 | 2 | IRAK3, KDR |
divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 2 | EDNRB, EDN3 |
regulation of blood vessel size (GO:0050880) | 4.8 | 2 | EDN3, EDNRB |
cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 2 | EDN3, EDNRB |
regulation of system process (GO:0044057) | 3.53 | 2 | EDN3, EDNRB |
catabolic process (GO:0009056) | 2.38 | 2 | DPYD, ZHX2 |
regulation of cell cycle process (GO:0010564) | 3.5 | 2 | EDN3, CREBBP |
positive regulation of neurogenesis (GO:0050769) | 3.77 | 2 | NTF3, RET |
cellular localization (GO:0051641) | 2.32 | 2 | PTCH1, TSC2 |
cellular response to endogenous stimulus (GO:0071495) | 3.33 | 2 | PLAU, FBN1 |
negative regulation of cell proliferation (GO:0008285) | 3.26 | 2 | PTCH1, TSC2 |
tube morphogenesis (GO:0035239) | 4.35 | 2 | PTCH1, GDNF |
melanocyte differentiation (GO:0030318) | 6.73 | 2 | EDN3, EDNRB |
regulation of body fluid levels (GO:0050878) | 3.76 | 2 | EDNRB, PLAU |
cell proliferation (GO:0008283) | 3.23 | 2 | CREBBP, PTCH1 |
cellular metal ion homeostasis (GO:0006875) | 3.75 | 2 | EDN3, EDNRB |
neurological system process (GO:0050877) | 2.64 | 2 | EDNRB, CNTN5 |
cellular ion homeostasis (GO:0006873) | 3.57 | 2 | EDNRB, EDN3 |
regulation of vesicle-mediated transport (GO:0060627) | 3.63 | 2 | NTF3, TSC2 |
mesonephric epithelium development (GO:0072163) | 5.8 | 2 | RET, GDNF |
mesonephric tubule development (GO:0072164) | 5.82 | 2 | RET, GDNF |
branching morphogenesis of an epithelial tube (GO:0048754) | 4.93 | 2 | PTCH1, GDNF |
cellular cation homeostasis (GO:0030003) | 3.6 | 2 | EDNRB, EDN3 |
ureteric bud development (GO:0001657) | 5.97 | 2 | RET, GDNF |
branching involved in ureteric bud morphogenesis (GO:0001658) | 5.97 | 2 | PTCH1, GDNF |
single organismal cell-cell adhesion (GO:0016337) | 3.69 | 2 | THBS4, RET |
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066) | 4.79 | 2 | KDR, TSC2 |
cell part morphogenesis (GO:0032990) | 3.99 | 2 | THBS4, NTF3 |
protein oligomerization (GO:0051259) | 3.71 | 2 | THBS4, AHNAK |
regulation of sequence-specific DNA binding transcription factor activity (GO:0051090) | 3.83 | 2 | IRAK3, PTCH1 |
regulation of axonogenesis (GO:0050770) | 4.59 | 2 | RET, SEMA3D |
cellular response to organic cyclic compound (GO:0071407) | 3.93 | 2 | PLAU, PTCH1 |
response to drug (GO:0042493) | 3.71 | 2 | RET, PTCH1 |
regulation of cell-matrix adhesion (GO:0001952) | 5.21 | 2 | PLAU, KDR |
regulation of metanephros development (GO:0072215) | 6.59 | 2 | RET, GDNF |
positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 2 | CREBBP, GDNF |
regulation of type I interferon production (GO:0032479) | 5.03 | 2 | POLR2F, CREBBP |
positive regulation of protein kinase activity (GO:0045860) | 3.61 | 2 | EDN3, NTF3 |
myeloid leukocyte migration (GO:0097529) | 5.13 | 2 | EDNRB, EDN3 |
positive regulation of cytokine production (GO:0001819) | 3.82 | 2 | POLR2F, CREBBP |
negative regulation of growth (GO:0045926) | 4.24 | 2 | PTCH1, SEMA3D |
regulation of peptidyl-serine phosphorylation (GO:0033135) | 4.98 | 2 | NTF3, RET |
peptidyl-tyrosine phosphorylation (GO:0018108) | 4.48 | 2 | RET, KDR |
glucose homeostasis (GO:0042593) | 4.6 | 2 | PLAU, PTCH1 |
regulation of blood pressure (GO:0008217) | 4.72 | 2 | EDN3, EDNRB |
angiogenesis (GO:0001525) | 4.15 | 2 | PLAU, KDR |
regulation of cell division (GO:0051302) | 4.88 | 2 | THBS4, PTCH1 |
regulation of ion transport (GO:0043269) | 3.4 | 2 | EDN3, AHNAK |
morphogenesis of an epithelium (GO:0002009) | 4.08 | 2 | PTCH1, GDNF |
positive regulation of nervous system development (GO:0051962) | 3.64 | 2 | NTF3, RET |
response to interleukin-1 (GO:0070555) | 5.07 | 2 | IRAK3, CREBBP |
regulation of angiogenesis (GO:0045765) | 4.36 | 2 | THBS4, KDR |
kidney epithelium development (GO:0072073) | 5.54 | 2 | RET, GDNF |
regulation of cell adhesion mediated by integrin (GO:0033628) | 6.04 | 2 | PLAU, RET |
regulation of cell maturation (GO:1903429) | 6.84 | 2 | EDNRB, RET |
extracellular structure organization (GO:0043062) | 4.0 | 2 | FBN1, KDR |
positive regulation of mitotic cell cycle (GO:0045931) | 4.98 | 2 | EDN3, CREBBP |
response to retinoic acid (GO:0032526) | 5.02 | 2 | RET, PTCH1 |
negative regulation of protein kinase activity (GO:0006469) | 4.29 | 2 | IRAK3, TSC2 |
positive regulation of innate immune response (GO:0045089) | 4.22 | 2 | IRAK3, CREBBP |
regulation of innate immune response (GO:0045088) | 3.86 | 2 | IRAK3, CREBBP |
morphogenesis of a branching epithelium (GO:0061138) | 4.77 | 2 | PTCH1, GDNF |
regulation of cell-substrate adhesion (GO:0010810) | 4.56 | 2 | PLAU, KDR |
cellular protein localization (GO:0034613) | 3.11 | 2 | PTCH1, TSC2 |
cation homeostasis (GO:0055080) | 3.46 | 2 | EDNRB, EDN3 |
regulation of metal ion transport (GO:0010959) | 3.94 | 2 | EDN3, AHNAK |
regulation of neuron maturation (GO:0014041) | 7.43 | 2 | EDNRB, RET |
metal ion homeostasis (GO:0055065) | 3.61 | 2 | EDNRB, EDN3 |
cell-cell signaling (GO:0007267) | 3.35 | 2 | EDN3, NTF3 |
positive chemotaxis (GO:0050918) | 6.17 | 2 | NTF3, TSC2 |
tube development (GO:0035295) | 4.41 | 2 | RET, GDNF |
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 4.68 | 2 | RET, FAT3 |
regulation of endocytosis (GO:0030100) | 4.42 | 2 | NTF3, TSC2 |
response to oxygen levels (GO:0070482) | 4.02 | 2 | CREBBP, PLAU |
heart development (GO:0007507) | 4.24 | 2 | FBN1, TSC2 |
cell projection morphogenesis (GO:0048858) | 4.05 | 2 | THBS4, NTF3 |
positive regulation of endothelial cell proliferation (GO:0001938) | 5.51 | 2 | THBS4, KDR |
regulation of ion homeostasis (GO:2000021) | 4.44 | 2 | EDNRB, KDR |
regulation of organ morphogenesis (GO:2000027) | 4.22 | 2 | PLAU, GDNF |
activation of immune response (GO:0002253) | 3.67 | 2 | IRAK3, CREBBP |
protein transport (GO:0015031) | 2.62 | 2 | PTCH1, TSC2 |
single-organism intracellular transport (GO:1902582) | 3.59 | 2 | PTCH1, TSC2 |
single-organism cellular localization (GO:1902580) | 3.16 | 2 | PTCH1, TSC2 |
cellular response to organonitrogen compound (GO:0071417) | 3.87 | 2 | PLAU, FBN1 |
regulation of endothelial cell proliferation (GO:0001936) | 5.14 | 2 | THBS4, KDR |